XML 58 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative Liabilities
12 Months Ended
Nov. 30, 2013
Notes to Financial Statements  
Derivative Liabilities

6.       Derivative Liabilities

 

The Company evaluated their convertible note agreements pursuant to ASC 815 and due to there being no minimum or fixed conversion price resulting in an indeterminate number of shares to be issued in the future, the Company determined an embedded derivative existed and ASC 815 applied for their convertible notes. The Company valued the embedded derivatives using the Black-Scholes valuation model.  

  

Convertible debt with a variable conversion feature

 

In 2013, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0.7 to 3 years; (2) a computed volatility rate of 229 to 283% (3) a discount rate of 0.13 to 0.25% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

 

In 2012, we estimated the fair value of the derivatives using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.5 years; (2) a computed volatility rate of 209 to 250% (3) a discount rate of 0.14 to 0.21% and (4) zero dividends.  Upon settlement the valuation of this embedded derivative was recorded as gain/loss on derivative liability.

 

Tainted conventional convertible debt

 

In 2013, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0 to 1.0 years; (2) a computed volatility rate of 232 to 243% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2012, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0.2 to 2.0 years; (2) a computed volatility rate of 243% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

Tainted stock options and warrants

 

The Company also evaluated all outstanding warrants and options to determine whether these instruments may be tainted. All warrants outstanding were considered tainted as a result of the tainted equity environment and potential inability of the Company to settle the instruments with shares of the Company’s stock as the number of shares issuable cannot be estimated and could exceed that amount of authorized shares available to be issued by the Company. The Company valued the embedded derivatives within the stock options and warrants using the Black-Scholes valuation model.  

 

In 2013, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 1.0 to 7.5 years; (2) a computed volatility rate of 232% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

In 2012, we estimated the fair value of the derivative using the Black-Scholes valuation method with assumptions including: (1) term of 0.2 to 8.5 years; (2) a computed volatility rate of 243% (3) a discount rate of 1% and (4) zero dividends.  The valuation of this embedded derivative was recorded with an offsetting gain/loss on derivative liability.

 

  

Activity for embedded derivative instruments during the year ended November 30, 2013 was as follows:

 

          Initial valuation                          
          of derivative                          
          liabilities upon     Change in                     
    Balance at     issuance of new    fair value of   Exercise of     Conversion     Balance at  
    November 30,   securities during   derivative     stock options/   of debt to     November 30,
    2012     the period     liabilities     warrants     equity   2013  
Variable convertible debt   $ 361,760     $ 3,307,991     $ (305,050)     $ -     $ (1,897,519   $ 1,467,182  
Tainted convertible debt     264,189               (124,236     -       -       139,953  
Tainted stock options     49,483       -       (19,140     -       -       30,343  
Tainted warrants     27,973       -       6,893               -       34,866  
    $ 703,405     $ 3,307,991     $ (441,533)     $ -     $ (1,897,519   $ 1,672,344  

 

 

Activity for embedded derivative instruments during the year ended November 30, 2012 was as follows:

 

      Initial valuation            
      of derivative            
      liabilities upon  Change in   Exercise of      
   Balance at  issuance of new  fair value of  stock  Conversion  Balance at
   November 30,  securities during  derivative  options/  of debt to  November 30,
   2011  the period  liabilities  warrants  equity  2012
Variable convertible debt  $274,909   $1,248,372   $(92,872)  $—     $(1,068,649)  $361,760 
Tainted convertible debt   —      —      264,189    —      —      264,189 
Tainted stock options   —      175,656    (126,173)   —      —      49,483 
Tainted warrants   —      93,768    (65,795)   —      —      27,973 
   $274,909   $1,517,796   $(20,651)  $—     $(1,068,649)  $703,405